Abstract

Accumulation of somatic mutations in the mitochondrial genome (mtDNA) has long been proposed as a possible mechanism of mitochondrial and tissue dysfunction that occurs during aging. A thorough characterization of age-associated mtDNA somatic mutations has been hampered by the limited ability to detect low frequency mutations. Here, we used Duplex Sequencing on eight tissues of an aged mouse cohort to detect >89,000 independent somatic mtDNA mutations and show significant tissue-specific increases during aging across all tissues examined which did not correlate with mitochondrial content and tissue function. G→A/C→T substitutions, indicative of replication errors and/or cytidine deamination, were the predominant mutation type across all tissues and increased with age, whereas G→T/C→A substitutions, indicative of oxidative damage, were the second most common mutation type, but did not increase with age regardless of tissue. We also show that clonal expansions of mtDNA mutations with age is tissue and mutation type dependent. Unexpectedly, mutations associated with oxidative damage rarely formed clones in any tissue and were significantly reduced in the hearts and kidneys of aged mice treated at late age with Elamipretide or nicotinamide mononucleotide. Thus, the lack of accumulation of oxidative damage-linked mutations with age suggests a life-long dynamic clearance of either the oxidative lesions or mtDNA genomes harboring oxidative damage.

Data availability

The Duplex-Seq-Pipeline is written in Python and R, but has dependencies written in other languages. The DuplexSeq-Pipeline software has been tested to run on Linux, Windows WSL1, Windows WSL2 and Apple OSX. The software can be obtained at https://github.com/KennedyLab-UW/Duplex-Seq-Pipeline. Raw mouse sequencing data used in this study are available at SRA accension PRJNA727407. The data from Arbeithuber et al. are available at SRA accension PRJNA563921. The final post-processed data, including variant call files, depth information, data summaries, and mutation frequencies, as well as the scripts to perform reproducible production of statistics and figure generation (with the exception of Figure 5C-E) are available at https://github.com/Kennedy-Lab-UW/Sanchez_Contreras_etal_2022.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Monica Sanchez-Contreras

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3092-2781
  2. Mariya T Sweetwyne

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    For correspondence
    sandu@uw.edu
    Competing interests
    No competing interests declared.
  3. Kristine A Tsantilas

    Department of Biochemistry, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4274-6930
  4. Jeremy A Whitson

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  5. Matthew D Campbell

    Department of Radiology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  6. Brenden F Kohrn

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9948-2131
  7. Hyeon Jeong Kim

    Department of Biology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  8. Michael J Hipp

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1904-0670
  9. Jeanne Fredrickson

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  10. Megan M Nguyen

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  11. James B Hurley

    Department of Biochemistry, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7754-0705
  12. David J Marcinek

    Department of Radiology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  13. Peter S Rabinovitch

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7169-3543
  14. Scott R Kennedy

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    For correspondence
    scottrk@uw.edu
    Competing interests
    Scott R Kennedy, is an equity holder and paid consultant for Twinstrand Biosciences, a for-profit company commercializing Duplex Sequencing. No Twinstrand products were used in the generation of the data..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4444-1145

Funding

National Institute on Aging (P01AG001751)

  • David J Marcinek
  • Peter S Rabinovitch

National Institute on Aging (K01AG062757)

  • Mariya T Sweetwyne

National Institute of Diabetes and Digestive and Kidney Diseases (R21DK128540)

  • Monica Sanchez-Contreras
  • Mariya T Sweetwyne

Congressionally Directed Medical Research Programs (W81XWH-16-1-0579)

  • Scott R Kennedy

National Human Genome Research Institute (R21HG011229)

  • Scott R Kennedy

National Cancer Institute (R21CA259780)

  • Scott R Kennedy

National Institute on Aging (T32AG000057)

  • Kristine A Tsantilas
  • Jeremy A Whitson

National Institute on Aging (T32AG066574)

  • Kristine A Tsantilas

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in accordance to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to an approved institutional animal care and use committee (IACUC) protocol (2174-23) at the University of Washington.

Copyright

© 2023, Sanchez-Contreras et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,280
    views
  • 383
    downloads
  • 31
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Monica Sanchez-Contreras
  2. Mariya T Sweetwyne
  3. Kristine A Tsantilas
  4. Jeremy A Whitson
  5. Matthew D Campbell
  6. Brenden F Kohrn
  7. Hyeon Jeong Kim
  8. Michael J Hipp
  9. Jeanne Fredrickson
  10. Megan M Nguyen
  11. James B Hurley
  12. David J Marcinek
  13. Peter S Rabinovitch
  14. Scott R Kennedy
(2023)
The multi-tissue landscape of somatic mtdna mutations indicates tissue specific accumulation and removal in aging
eLife 12:e83395.
https://doi.org/10.7554/eLife.83395

Share this article

https://doi.org/10.7554/eLife.83395

Further reading

    1. Developmental Biology
    2. Genetics and Genomics
    Anne-Sophie Pepin, Patrycja A Jazwiec ... Sarah Kimmins
    Research Article Updated

    Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome, and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, altered sperm H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of de-regulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity effects on placenta development and function as one potential developmental route to offspring metabolic disease.

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Federico A Vignale, Andrea Hernandez Garcia ... Adrian G Turjanski
    Research Article

    Yerba mate (YM, Ilex paraguariensis) is an economically important crop marketed for the elaboration of mate, the third-most widely consumed caffeine-containing infusion worldwide. Here, we report the first genome assembly of this species, which has a total length of 1.06 Gb and contains 53,390 protein-coding genes. Comparative analyses revealed that the large YM genome size is partly due to a whole-genome duplication (Ip-α) during the early evolutionary history of Ilex, in addition to the hexaploidization event (γ) shared by core eudicots. Characterization of the genome allowed us to clone the genes encoding methyltransferase enzymes that catalyse multiple reactions required for caffeine production. To our surprise, this species has converged upon a different biochemical pathway compared to that of coffee and tea. In order to gain insight into the structural basis for the convergent enzyme activities, we obtained a crystal structure for the terminal enzyme in the pathway that forms caffeine. The structure reveals that convergent solutions have evolved for substrate positioning because different amino acid residues facilitate a different substrate orientation such that efficient methylation occurs in the independently evolved enzymes in YM and coffee. While our results show phylogenomic constraint limits the genes coopted for convergence of caffeine biosynthesis, the X-ray diffraction data suggest structural constraints are minimal for the convergent evolution of individual reactions.